Neuromodulator and Dermal Filler Use In Dentistry – Introduction and Applied Head & Neck Anatomy 2024-2025 Calendar Year

Neuromodulator and Dermal Filler Use In Dentistry – Introduction and Applied Head & Neck Anatomy 2024-2025 Calendar Year

Course date: October 15, 2024 – May 30, 2025

ONLINE with Asynchronous delivery

Description

“Botulinum toxin blocks neuromuscular transmission by binding to acceptor sites on motor nerve terminals and inhibiting the release of acetylcholine.  Injectable drugs (neuromodulators) derived from this paralytic agent are listed in Schedule 1 of the Manual for Canada’s National Drug Scheduling System published by the National Association of Pharmacy Regulatory Authorities.”   ( referenced from the Manitoba Dental Association Bylaw for the Use of Neuromodulators and Dermal Fillers).  Neuromodulators have been used both cosmetically and therapeutically to treat both the muscles of facial expression as well as the masticatory muscles in temporomandibular dysfunction and other parafunction.  The use of neuromodulators may include treatment for the management of bruxism that includes clenching and grinding as well as treatment and management of myofascial pain that includes headaches and migraines.  Understanding the mechanism of action of neuromodulators will help to educate the provider and patient to understand what the injectables can do, and more importantly, what their limitations are.

“The use of dermal fillers for the treatment of the naso-labial fold, lip augmentation, gingival augmentation and other areas of the face, including but not limited to: malar enhancement, treatment of the nasojugal groove, and the treatment of glabellar, laugh and marionette lines.” (referenced from the Manitoba Dental Association Bylaw for the Use of Neuromodulators and Dermal Fillers).  The techniques involving injectable dermal fillers is used to increase facial volume, enhance lips and reduce deep facial lines and folds.

Understanding the injectable substance and knowing how to navigate the full facial, head and neck anatomy in hands-on anatomical e-cadaver lab sessions will enable the health provider to administer the injectable with confidence and aid in providing acceptable outcomes and help to prevent complications.

This course is presented as an asynchronous offering on UM Learn, providing 8 hours of didactic instruction that will cover an introduction of neuromodulators and dermal fillers and include discussion of the pharmacological and physiological considerations of its use.  A comprehensive review of head and neck surface anatomy, muscles of facial expression, muscles of mastication, cervical musculature, relevant vascular anatomy, and neural considerations as well as the temporomandibular joint complex will be presented and discussed.  This course will include a 4-hour e-cadaver session using the same platform. Please note that the e-cadaver session may be distributed within the didactic course material to enhance learning.

Successful completion of a formal written evaluation and full attendance of lecture and cadaver lab sessions are required to receive a Certificate of Completion and is intended to be compliant with Section I, 1.a.i, Section II, 1.a.i and Section III, 1.b.i of the Manitoba Dental Association Bylaw for the Use of Neuromodulators and Dermal Fillers.  Note:  This course is the first of a 3-course series to become eligible to roster according to the MDA Bylaw.

Scope of practice is dictated by provincial dental regulatory bodies that determine which professional group can administer neuromodulators for therapeutic and cosmetic uses.  It is the responsibility of the Participant to understand the regulatory requirements for this scope of practice respective to their jurisdiction of practice.    See Flowchart for the course path to roster according to the MDA Bylaw for the Use of Neuromodulators and Dermal Fillers.  Flowchart_NMD.DF_v3 

Learning Objectives

• Understand the full facial, head and neck anatomy to include musculature, vascular and neural considerations with focus on the upper facial, mid-facial, lower facial and neck region, as well as the temporomandibular joint in addition to the pharmacology and physiology relevant to neuromodulator and dermal filler use
• Anatomic comprehension of where the injections are aimed and what structures to avoid utilizing hands-on cadaver lab sessions
• Understand the therapeutic and cosmetic uses of neuromodulators
• Understand the cosmetic use of dermal fillers
• Know the risks and complications of injecting neuromodulators and dermal fillers
• Understand the benefits and limitations of neuromodulators and dermal fillers
• Understand record keeping and documentation principles for neuromodulator and dermal filler use

Full attendance of the course, Bylaw Module I-A/B Anatomy (Neuromodulator and Dermal Filler Use in Dentistry – Introduction and Applied Head & Neck Anatomy) course by CPD Dentistry and Dental Hygiene, Dr. Gerald Niznick College of Dentistry, University of Manitoba and successful completion of the formal assessment examination, or an equivalent course recognized by the respective dental regulatory authority is required to move forward with subsequent courses in this series and for accessing future courses associated with this subject area.

Instructor(s)

Dr. Sherif Elsaraj  B.Sc., M.Sc., D.M.D, Ph.D

Dr. Elsaraj was raised in Ottawa where he attended JS Wordsworth Secondary School followed by a B.Sc. Honours in Biochemistry from Carleton University (2004). He then completed his M.Sc. in Oral Biology (2006) and Doctor of Medicine in Dentistry (2010), both at the University of Manitoba, and a Ph.D. in Craniofacial Pain and Health Sciences from McGill University (2022).

Dr Elsaraj is an active member of the Canadian Dental Association (CDA), Manitoba Dental Association (MDA), Ontario Dental Association (ODA), and the Order des Dentists du Quebec. Dr. Elsaraj is a Faculty Lecturer with the University of Ottawa (Faculty of Medicine), McGill University (Department of Dentistry at the Jewish General Hospital) where he lectures and supervises graduate residents of the General Residency Program of Orofacial Pain (OFP) & Temporomandibular disorders (TMD) & Clinic. He is the current Chair of Continuing Education committee of the Ottawa Dental Society (ODS), Executive Treasurer (ODS), Executive Council (ODS & ODA), and Economics Committee Advisor (ODA). He is also an active member of the American Academy of Dental Sleep Medicine, Political Contact dentist- Nepean West (ODS), Dental Emergency Service (ODS), Long Term Planning Committee (ODS), a TMD consultant for the Oral Health Group and Hull Hospital, a Dental Advisor for the Canadian Academy of Clinical Sleep Disorders Disciplines (CACSDD), and a Certified Botox Provider.

Dr. Elsaraj engages in research at McGill University Jewish General Hospital Campus and the Centre de recherche en médecine psychosociale du CISSS de l’Outaouais. His focus includes identifying biomarkers for early detection of sleep apnea, exploring risk factors linked to the transition from acute to chronic pain, and evaluating the effectiveness of new bite techniques in MAD therapy to mitigate the severity of sleep apnea.

Registration Fee:

Dentist/Health Practitioner:    $1750.00 (CAD)

Refund Policy

Registrants may receive a refund provided they give written notice to withdraw prior to the event. An administration fee will be retained to cover staff costs of processing refunds and other costs associated with cancellations.  Refund requests with written notice to withdraw received by CPD will be at the discretion of the Director of Continuing Professional Development for Dentistry and Dental Hygiene.  No refunds will be considered fourteen (14) days or less prior to date of first day of event.

The University of Manitoba reserves the right to cancel or postpone any educational program due to an insufficient number of registrations. The decision to cancel will normally be made at least fourteen (14) days prior to the program date. Each registrant will be notified by email and provided with a full refund of all registration costs. The University of Manitoba is not liable for any loss, damages or other expenses that such cancellations may cause, including, but not limited to, non-refundable airline fares, hotel penalties or lost income.

Study Credits

This course provides up to 12.0 hours of Continuing Dental Education (CDE) Credits.

Rady Faculty of Health Sciences, University of Manitoba Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. The current term of approval extends from July 1, 2022 to June 30, 2026. Provider ID# 214210 Subject Code 012